172 related articles for article (PubMed ID: 25633671)
21. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.
Lidström AM; Bogdanovic N; Hesse C; Volkman I; Davidsson P; Blennow K
Exp Neurol; 1998 Dec; 154(2):511-21. PubMed ID: 9878186
[TBL] [Abstract][Full Text] [Related]
22. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
Reinikainen KJ; Soininen H; Riekkinen PJ
J Neurosci Res; 1990 Dec; 27(4):576-86. PubMed ID: 1981917
[TBL] [Abstract][Full Text] [Related]
23. Altered p59Fyn kinase expression accompanies disease progression in Alzheimer's disease: implications for its functional role.
Ho GJ; Hashimoto M; Adame A; Izu M; Alford MF; Thal LJ; Hansen LA; Masliah E
Neurobiol Aging; 2005 May; 26(5):625-35. PubMed ID: 15708437
[TBL] [Abstract][Full Text] [Related]
24. Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains.
Clark EA; Leach KL; Trojanowski JQ; Lee VM
Lab Invest; 1991 Jan; 64(1):35-44. PubMed ID: 1990207
[TBL] [Abstract][Full Text] [Related]
25. Cofilin rods and aggregates concur with tau pathology and the development of Alzheimer's disease.
Rahman T; Davies DS; Tannenberg RK; Fok S; Shepherd C; Dodd PR; Cullen KM; Goldsbury C
J Alzheimers Dis; 2014; 42(4):1443-60. PubMed ID: 25024349
[TBL] [Abstract][Full Text] [Related]
26. Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease.
Vermeiren Y; Van Dam D; Aerts T; Engelborghs S; De Deyn PP
J Alzheimers Dis; 2014; 41(3):819-33. PubMed ID: 24685637
[TBL] [Abstract][Full Text] [Related]
27. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
[TBL] [Abstract][Full Text] [Related]
28. Ubiquilin-1 immunoreactivity is concentrated on Hirano bodies and dystrophic neurites in Alzheimer's disease brains.
Satoh J; Tabunoki H; Ishida T; Saito Y; Arima K
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):817-30. PubMed ID: 23421764
[TBL] [Abstract][Full Text] [Related]
29. Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-β load and cognitive decline in Alzheimer's disease.
Morawski M; Schilling S; Kreuzberger M; Waniek A; Jäger C; Koch B; Cynis H; Kehlen A; Arendt T; Hartlage-Rübsamen M; Demuth HU; Roßner S
J Alzheimers Dis; 2014; 39(2):385-400. PubMed ID: 24164736
[TBL] [Abstract][Full Text] [Related]
30. Brain interleukin-1 beta in Alzheimer's disease and vascular dementia.
Cacabelos R; Alvarez XA; Fernández-Novoa L; Franco A; Mangues R; Pellicer A; Nishimura T
Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):141-51. PubMed ID: 8007743
[TBL] [Abstract][Full Text] [Related]
31. BACE1 mRNA expression in Alzheimer's disease postmortem brain tissue.
Coulson DT; Beyer N; Quinn JG; Brockbank S; Hellemans J; Irvine GB; Ravid R; Johnston JA
J Alzheimers Dis; 2010; 22(4):1111-22. PubMed ID: 20930286
[TBL] [Abstract][Full Text] [Related]
32. Differential neuronal expression of manganese superoxide dismutase in Alzheimer's disease.
Marcus DL; Strafaci JA; Freedman ML
Med Sci Monit; 2006 Jan; 12(1):BR8-14. PubMed ID: 16369462
[TBL] [Abstract][Full Text] [Related]
33. N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease.
Gironès X; Guimerà A; Cruz-Sánchez CZ; Ortega A; Sasaki N; Makita Z; Lafuente JV; Kalaria R; Cruz-Sánchez FF
Free Radic Biol Med; 2004 May; 36(10):1241-7. PubMed ID: 15110389
[TBL] [Abstract][Full Text] [Related]
34. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.
Albasanz JL; Dalfó E; Ferrer I; Martín M
Neurobiol Dis; 2005 Dec; 20(3):685-93. PubMed ID: 15949941
[TBL] [Abstract][Full Text] [Related]
35. Regulatory control of human cytosolic branched-chain aminotransferase by oxidation and S-glutathionylation and its interactions with redox sensitive neuronal proteins.
Conway ME; Coles SJ; Islam MM; Hutson SM
Biochemistry; 2008 May; 47(19):5465-79. PubMed ID: 18419134
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease.
Kirvell SL; Esiri M; Francis PT
J Neurochem; 2006 Aug; 98(3):939-50. PubMed ID: 16893425
[TBL] [Abstract][Full Text] [Related]
37. Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease.
van Helmond ZK; Miners JS; Bednall E; Chalmers KA; Zhang Y; Wilcock GK; Love S; Kehoe PG
Neuropathol Appl Neurobiol; 2007 Jun; 33(3):317-27. PubMed ID: 17493012
[TBL] [Abstract][Full Text] [Related]
38. Density of Sgt1-immunopositive neurons is decreased in the cerebral cortex of Alzheimer's disease brain.
Spiechowicz M; Bernstein HG; Dobrowolny H; Leśniak W; Mawrin C; Bogerts B; Kuźnicki J; Filipek A
Neurochem Int; 2006 Oct; 49(5):487-93. PubMed ID: 16698122
[TBL] [Abstract][Full Text] [Related]
39. [Brain volume changes of patients with Alzheimer's disease in two years: a case control study].
Wang T; Xiao SF; Li X; Zhu MJ; Hao J; Ding B; Ling HW; Chen KM
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1027-31. PubMed ID: 18754434
[TBL] [Abstract][Full Text] [Related]
40. Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood-brain barrier breakdown.
Levin EC; Acharya NK; Han M; Zavareh SB; Sedeyn JC; Venkataraman V; Nagele RG
Brain Res; 2010 Jul; 1345():221-32. PubMed ID: 20546711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
